Orphan drugs are medications developed specifically to treat rare diseases, affecting fewer than 200,000 people in the United States. The Orphan Drug Act provides incentives like tax credits and market exclusivity to encourage the development of these drugs. Some gynecological conditions, such as certain types of ovarian cancer, may qualify for orphan drug status.
